Shane E. Brogan
Rating: 4.8 of 5
( out of 96 reviews )

Shane E. Brogan, MD

Languages spoken: French, English, Irish

Clinical Locations

Primary Location

Pain Management Center

615 Arapeen Dr.
Salt Lake City , UT 84108
801-581-7246
Get Directions

University of Utah Hospital

Anesthesiology
50 N Medical Dr
Salt Lake City , UT 84132
801-581-6393
Get Directions

  • Shane E. Brogan, MB BCh, is a professor of Anesthesiology at the University of Utah School of Medicine, and pain physician at Huntsman Cancer Institute. Dr. Brogan's clinical and research interests are in the management of complex cancer pain and cancer survivor pain. As a member of the Huntsman Cancer Intstitute Supportive Oncology and Survivorship team, Dr Brogan works with patients to provide advanced cancer pain management with an emphasis on restoration of quality of life. Dr Brogan's areas of expertise include medication management, injection therapies, and intrathecal (spinal cord) pain pump therapy. Dr Brogan also practices at the University Pain Management Center, as a member of its interdisciplinary pain management team.


    An Irish citizen, he received his medical degree from the Royal College of Surgeons in Ireland Medical School in 1997. After a residency in Anesthesiology, Dr Brogan did a Pain Medicine fellowship at the University of Utah, and is board-certified in Anesthesiology and in Pain Medicine.

    Specialties

    Patient Rating

    Rating: 4.8 out of 5
    4.8 /5
    ( out of 96 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr Brogan is very professional, but is also very personable.

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    He is a compassionate, expert provider. He listens to the patient and will adjust treatment plan based on patient feedback. I am pleased to have him as part of my care team.

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    I have visited with Dr Brogan on his office many times and he has performed several procedures to help with the pain in my back. All of these times I have found the Doctor and his staff to be very; courteous, knowledgeable and easy to work with.

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Brogan always listens to my concerns and answers my questions. He is knowledgeable, caring, and supports me in achieving my pain management goals.

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Great doctor. Listens and finds solutions.

    Huntsman Cancer Institute
    Rating: 5 out of 5

    Dr. Brogan is great - always wants to know how I'm doing with my pain management; is there anything else he can do to help me be comfortable; explains things very well; answers my questions

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    He is very knowledgeable and good beside manners

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Brogan is one of the best providers I have ever had on my care team. He is both professional and caring about my individual needs. He is consistently trying to improve my quality of life and he listens to everything I say in its entirety, never seems rushed or impatient. I am thankful that providers like him exist.

    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    We tend to work in boxes or silos. My unusual medical problem required out-of-box thinking. Dr. Brogan did not try to remember how to treat it - he focused on solving it.

  • Shane E. Brogan, MB BCh, is a professor of Anesthesiology at the University of Utah School of Medicine, and pain physician at Huntsman Cancer Institute. Dr. Brogan's clinical and research interests are in the management of complex cancer pain and cancer survivor pain. As a member of the Huntsman Cancer Intstitute Supportive Oncology and Survivorship team, Dr Brogan works with patients to provide advanced cancer pain management with an emphasis on restoration of quality of life. Dr Brogan's areas of expertise include medication management, injection therapies, and intrathecal (spinal cord) pain pump therapy. Dr Brogan also practices at the University Pain Management Center, as a member of its interdisciplinary pain management team.


    An Irish citizen, he received his medical degree from the Royal College of Surgeons in Ireland Medical School in 1997. After a residency in Anesthesiology, Dr Brogan did a Pain Medicine fellowship at the University of Utah, and is board-certified in Anesthesiology and in Pain Medicine.

    Board Certification and Academic Information

    Academic Departments Anesthesiology -Professor (Clinical)

    Education history

    Professional Medical Medical School - Royal College of Surgeons - Ireland M.B.B.Ch.
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Residency Anesthesiology - University of Utah School of Medicine Resident
    Fellowship Anesthesiology - University of Utah School of Medicine Fellow

    Selected Publications

    Journal Article

    1. Brogan SE, Sindt JE, Jackman CM, White J, Wilding V, Okifuji (2020). Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy. Anesthesia and analgesia, 130(4), 1035-1044. (Read full publication)
    2. Brogan SE, Cahalan M (2005). Gatifloxacin as a possible cause of serious postoperative hypoglycemia. Anesthesia and analgesia, 101(3), 635-6, table of contents. (Read full publication)
    3. Brogan S (2006). Intrathecal therapy for the management of cancer pain. Current pain and headache reports, 10(4), 254-9. (Read full publication)
    4. Brogan SE, Winter NB, Abiodun A, Safarpour (2013). A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit. Pain medicine (Malden, Mass.), 14(4), 478-86. (Read full publication)
    5. Odell DW, Albrechtsen RD, Sindt JE, Gole R, Brown S, Parsons MW, Paxton AB, Sarkar V, Lloyd S, Brogan SE, Tao (2021). The Effect of Measured Radiotherapy Dose on Intrathecal Drug Delivery System Function. Neuromodulation, 24(7), 1204-1208. (Read full publication)
    6. Perruchoud C, Dupoiron D, Papi B, Calabrese A, Brogan S (2022). Management of Cancer-Related Pain With Intrathecal Drug Delivery: A Systematic Review and Meta-Analysis of Clinical Studies. Neuromodulation, (Read full publication)
    7. Sindt JE, Odell DW, Tariq R, Presson AP, Zhang C, Brogan S (2021). Initial Intrathecal Dose Titration and Predictors of Early Dose Escalation in Patients With Cancer Using a 100:1 Oral to Intrathecal Morphine Conversion Ratio. Neuromodulation, 24(7), 1157-1166. (Read full publication)
    8. Aman MM, Mahmoud A, Deer T, Sayed D, Hagedorn JM, Brogan SE, Singh V, Gulati A, Strand N, Weisbein J, Goree JH, Xing F, Valimahomed A, Pak DJ, El Helou A, Ghosh P, Shah K, Patel V, Escobar A, Schmidt K, Shah J, Varshney V, Rosenberg W, Narang (2021). The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain. Journal of pain research, 14, 2139-2164. (Read full publication)
    9. Brogan SE, Sindt JE, Odell D (2021). Quantitative Assessment of the Incidence of Persistent Orthostatic Hemodynamic Changes After Celiac Plexus Neurolysis: A Prospective Case Series. A&A practice, 15(5), e01470. (Read full publication)
    10. Sindt JE, Odell DW, Dalley AP, Brogan S (2020). Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer. Neuromodulation, 23(7), 978-983. (Read full publication)
    11. Brogan SE, Sindt JE, Odell DW, Gulati A, Dupoiron (2022). Controversies in intrathecal drug delivery for cancer pain. Regional anesthesia and pain medicine, 48(6), 319-325. (Read full publication)
    12. Brogan SE, Odell DW, Sindt JE, Yi I, Chrisman OM, Zhang C, Presson A (2022). Dorsal vs Ventral Intrathecal Catheter Tip Location and Effect on Dose Escalation and Opioid Use in Patients With Cancer Pain. Neuromodulation, 26(6), 1233-1239. (Read full publication)
    13. Abdullah N, Sindt JE, Whittle J, Anderson JS, Odell DW, Mahan M, Brogan SE (2023). Impact of Neuromodulation on Opioid Use, Adjunct Medication Use, and Pain Control in Cancer-Related Pain: A Retrospective Case Series. Pain medicine (Malden, Mass.), epub ahead of print,
    14. Gabay S, Sapir Y, Korn A, Hochberg U, Tellem R, Zegerman A, Brogan SE, Rahimpour S, Shofty B, Strauss (2024). Optimization of Radiofrequency Needle Placement in Percutaneous Cordotomy Using Electromyography in the Deeply Sedated Patient. Operative neurosurgery (Hagerstown, Md.), 26(1), 22-27. (Read full publication)
    15. Sindt JE, Fitzgerald LA, Kuznicki J, Prelewicz S, Odell DW, Brogan S (2023). Antiplatelet and Wound Healing Implications of Immunotherapy and Targeted Cancer Therapies in the Perioperative Period. Anesthesiology, 139(4), 511-522. (Read full publication)
    16. Deer TR, Hayek SM, Grider JS, Pope JE, Brogan SE, Gulati A, Hagedorn JM, Strand N, Hah J, Yaksh TL, Staats PS, Perruchoud C, Knezevic NN, Wallace MS, Pilitsis JG, Lamer TJ, Buchser E, Varshney V, Osborn J, Goel V, Simpson BA, Lopez JA, Dupoiron D, Saulino MF, McDowell GC 2nd, Piedimonte F, Levy R (2024). The Polyanalgesic Consensus Conference (PACC)®: Updates on Clinical Pharmacology and Comorbidity Management in Intrathecal Drug Delivery for Cancer Pain. Neuromodulation, (Read full publication)